Molecular and Biochemical Therapeutic Strategies for Duchenne Muscular Dystrophy. [PDF]
Krishna L +6 more
europepmc +1 more source
Prostaglandins limit nuclear actin rod formation during <i>Drosophila</i> oogenesis. [PDF]
Tootle TL.
europepmc +1 more source
Gene Editing for Duchenne Muscular Dystrophy: From Experimental Models to Emerging Therapies. [PDF]
Haque US, Yokota T, Yokota T.
europepmc +1 more source
The potential of utrophin and dystrophin combination therapies for Duchenne muscular dystrophy
Simon Guiraud +7 more
openalex +2 more sources
Potential limitations of microdystrophin gene therapy for Duchenne muscular dystrophy. [PDF]
Hart CC +6 more
europepmc +1 more source
3D-QSAR Modeling on 2-Pyrimidine Carbohydrazides as Utrophin Modulators for the Treatment of Duchenne Muscular Dystrophy by Combining CoMFA, CoMSIA, and Molecular Docking Studies. [PDF]
Mahmoudzadeh Laki R, Pourbasheer E.
europepmc +1 more source
Targeting EP2 Receptor Improves Muscle and Bone Health in Dystrophin<sup>-/-</sup>/Utrophin<sup>-/-</sup> Double-Knockout Mice. [PDF]
Gao X +7 more
europepmc +1 more source

